Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vivani Medical, Inc. - Common Stock
(NQ:
VANI
)
1.180
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,932
Open
1.180
Bid (Size)
1.180 (1)
Ask (Size)
1.210 (32)
Prev. Close
1.180
Today's Range
1.180 - 1.180
52wk Range
1.000 - 7.800
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
December 19, 2024
From
Vivani Medical, Inc.
Via
Business Wire
EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia
December 19, 2024
Vivani Medical launches first-in-human trial of its exenatide implant in Australia, aiming to support chronic weight management with innovative GLP-1 technology.
Via
Benzinga
Performance
YTD
+13.46%
+13.46%
1 Month
-11.94%
-11.94%
3 Month
-2.48%
-2.48%
6 Month
-4.07%
-4.07%
1 Year
+4.42%
+4.42%
More News
Read More
Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast
December 04, 2024
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results
November 13, 2024
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024
October 22, 2024
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
September 26, 2024
From
Vivani Medical, Inc.
Via
Business Wire
EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia
September 26, 2024
Via
Benzinga
Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024
September 23, 2024
From
Vivani Medical, Inc.
Via
Business Wire
Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant
September 04, 2024
From
Vivani Medical, Inc.
Via
Business Wire
EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity
September 04, 2024
Via
Benzinga
Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
August 28, 2024
From
Vivani Medical, Inc.
Via
Business Wire
VANI Stock Earnings: Vivani Medical Beats EPS for Q2 2024
August 13, 2024
Via
InvestorPlace
Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results
August 13, 2024
From
Vivani Medical, Inc.
Via
Business Wire
Pineapple Financial And 1 Other Stock Under $1 Insiders Are Buying
August 05, 2024
Via
Benzinga
Vivani Medical And 2 Other Stocks Under $2 Insiders Are Buying
August 02, 2024
Via
Benzinga
Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115
July 11, 2024
From
Vivani Medical, Inc.
Via
Business Wire
EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year
July 11, 2024
Via
Benzinga
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 13, 2024
Via
Benzinga
Why GLP-1 Developer Vivani Medical's Stock Is Climbing
June 13, 2024
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 13, 2024
Via
Benzinga
Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant
June 13, 2024
From
Vivani Medical, Inc.
Via
Business Wire
EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's NDA Gains FDA Clearance For Clinical Use
June 13, 2024
Via
Benzinga
Exposures
Product Safety
Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant
May 28, 2024
From
Vivani Medical, Inc.
Via
Business Wire
EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use
May 28, 2024
Via
Benzinga
VANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024
May 13, 2024
Via
InvestorPlace
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.